Page last updated: 2024-08-25

nedaplatin and Cancer of the Ureter

nedaplatin has been researched along with Cancer of the Ureter in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujikawa, A; Kohno, M; Moriyama, M; Namura, K; Ota, J; Sawada, T; Yamada, Y1
Kamata, S; Yoshinaga, A1
Fukuta, F; Kitamura, H; Kunishima, Y; Masumori, N; Mutoh, M; Shigyo, M; Taguchi, K; Takahashi, A; Tanaka, T; Tsukamoto, T; Yanase, M1
Baba, S; Hirai, S; Ishkawa, W; Iwamura, M; Maru, N; Nishi, M; Shimizu, T; Sugita, Y; Yokota, S1
Kubota, Y; Makiyama, K; Miyoshi, Y; Nakaigawa, N; Ogawa, T; Sugiura, S; Uemura, H; Umemoto, S; Yao, M; Yokomizo, Y1

Reviews

1 review(s) available for nedaplatin and Cancer of the Ureter

ArticleYear
[Successful gemcitabine-nedaplatin therapy in a hemodialysis patient with ureteral carcinoma after bilateral nephroureterectomy].
    Hinyokika kiyo. Acta urologica Japonica, 2012, Volume: 58, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Male; Nephrectomy; Organoplatinum Compounds; Renal Dialysis; Ureter; Ureteral Neoplasms

2012

Trials

1 trial(s) available for nedaplatin and Cancer of the Ureter

ArticleYear
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
    Cancer science, 2011, Volume: 102, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms

2011

Other Studies

3 other study(ies) available for nedaplatin and Cancer of the Ureter

ArticleYear
[Successful combination chemotherapy of gemcitabine plus nedaplatin for invasive ureteral squamous cell carcinoma].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2014, Volume: 105, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Female; Gemcitabine; Humans; Organoplatinum Compounds; Ureteral Neoplasms

2014
[Long survival in a patient with advanced ureteral carcinoma treated with TIN regimen (paclitaxel, ifosfamide, nedaplatin) and radiotherapy : a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2014, Volume: 60, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Humans; Ifosfamide; Male; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Ureteral Neoplasms

2014
[A case of salvage combination chemotherapy of gemcitabine plus nedaplatin for squamous cell carcinoma of the ureter].
    Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Male; Middle Aged; Organoplatinum Compounds; Salvage Therapy; Ureteral Neoplasms

2006